15 results
424B3
AMYT
Amryt Pharma Plc
1 Jul 21
Prospectus supplement
5:20pm
company.
Chiasma is a target of a lawsuit that could result in substantial costs and may delay or prevent the merger from being completed … and the key inputs for the financial analyses performed by Duff & Phelps. The lawsuit seeks various remedies,
including a preliminary and/or permanent
F-4/A
AMYT
Amryt Pharma Plc
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
interest after the merger and will exercise less influence over the management of the combined company.
Chiasma is a target of a lawsuit that could result … & Phelps. The lawsuit seeks various remedies,
including a preliminary and/or permanent injunction prohibiting consummation of the proposed
20-F
2020 FY
AMYT
Amryt Pharma Plc
30 Apr 21
Annual report (foreign)
12:53pm
infringement lawsuit against a biosimilar or interchangeable product sponsor. Unlike the Hatch-Waxman Act, the BPCI Act provides no automatic stay
424B4
wash k6wfdml
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
xv2eg0mxot9l0tya32
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
e01zb34
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
dht eukzgg
18 Dec 20
Draft registration statement
12:00am
424B4
7raq8jahzvinw2rzth8a
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
4e2cmej941xz2d5a
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
8korvdxhtqvv2y
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.1
z1ag qbpiqmzt5
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
ekhw168gb4gzny 3lb
29 May 20
Draft registration statement (amended)
12:00am
DRS
6zt8n
19 Feb 20
Draft registration statement
12:00am
- Prev
- 1
- Next